key: cord-1035602-grwyhs04
authors: Huang, J.; Zheng, L.; Li, Z.; Hao, S.; Ye, F.; Chen, J.; Yao, X.; Liao, J.; Wang, S.; Zeng, M.; Qiu, L.; Cen, F.; Huang, Y.; Zhu, T.; Xu, Z.; Ye, M.; Yang, Y.; Wang, G.; Li, J.; Wang, L.; Qu, J.; Yuan, J.; Zheng, W.; Zhang, Z.; Li, C.; Whitin, J. C.; Tian, L.; Chubb, H.; Hwa, K.; Gans, H. A.; Ceresnak, S. R.; Zhang, W.; Lu, Y.; Maldonado, Y. A.; Cohen, H. J.; McElhinney, D. B.; Sylvester, K. G.; He, Q.; Wang, Z.; Liu, Y.; Liu, L.; Ling, X. B.
title: Recurrence of SARS-CoV-2 PCR positivity in COVID-19 patients: a single center experience and potential implications
date: 2020-05-10
journal: nan
DOI: 10.1101/2020.05.06.20089573
sha: 3074b51f9b6134655dffc154c8b99442047337d7
doc_id: 1035602
cord_uid: grwyhs04

IMPORTANCE How to appropriately care for patients who become PCR-negative for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still not known. Patients who have recovered from coronavirus disease 2019 (COVID-19) could profoundly impact the health care system if a subset were to be PCR-positive again with reactivated SARS-CoV-2. OBJECTIVE To characterize a single center COVID-19 cohort with and without recurrence of PCR positivity, and develop an algorithm to identify patients at high risk of retest positivity after discharge to inform health care policy and case management decision-making. DESIGN, SETTING, AND PARTICIPANTS A cohort of 414 patients with confirmed SARS-CoV-2 infection, at The Second Affiliated Hospital of Southern University of Science and Technology in Shenzhen, China from January 11 to April 23, 2020. EXPOSURES Polymerase chain reaction (PCR) and IgM-IgG antibody confirmed SARS-CoV-2 infection. MAIN OUTCOMES AND MEASURES Univariable and multivariable statistical analysis of the clinical, laboratory, radiologic image, medical treatment, and clinical course of admission/quarantine/readmission data to develop an algorithm to predict patients at risk of recurrence of PCR positivity. RESULTS 16.7% (95CI: 13.0%-20.3%) patients retest PCR positive 1 to 3 times after discharge, despite being in strict quarantine. The driving factors in the recurrence prediction model included: age, BMI; lowest levels of the blood laboratory tests during hospitalization for cholinesterase, fibrinogen, albumin, prealbumin, calcium, eGFR, creatinine; highest levels of the blood laboratory tests during hospitalization for total bilirubin, lactate dehydrogenase, alkaline phosphatase; the first test results during hospitalization for partial pressure of oxygen, white blood cell and lymphocyte counts, blood procalcitonin; and the first test episodic Ct value and the lowest Ct value of the nasopharyngeal swab RT PCR results. Area under the ROC curve is 0.786. CONCLUSIONS AND RELEVANCE This case series provides clinical characteristics of COVID-19 patients with recurrent PCR positivity, despite strict quarantine, at a 16.7% rate. Use of a recurrence prediction algorithm may identify patients at high risk of PCR retest positivity of SARS-CoV-2 and help modify COVID-19 case management and health policy approaches.

during hospitalization for cholinesterase, fibrinogen, albumin, prealbumin, calcium, eGFR, creatinine; highest levels of the blood laboratory tests during hospitalization for total bilirubin, lactate dehydrogenase, alkaline phosphatase; the first test results during hospitalization for partial pressure of oxygen, white blood cell and lymphocyte counts, blood procalcitonin; and the first test episodic Ct value and the lowest Ct value of the nasopharyngeal swab RT PCR results. Area under the ROC curve is 0.786. 

Given the sudden emergence and rapid community transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) being observed worldwide, a strategy of social distancing and shelter in place has been widely adopted in an effort to curb the spread of COVID-19 across space and time 1, 2 . The quarantining of patients testing positive for SARS-CoV-2 virus is considered mandatory in order to prevent continued viral spread (contagion). In last 6 months, many of COVID-19 patients have since clinically recovered and been discharged from the hospital, but it remains unclear the degree to which patients with COVID-19 (clinical symptoms and PCR test positivity) remain contagious and or at risk for disease relapse. The rising concern is that COVID-19 discharged patients may be at risk of viral reactivation to infect others as asymptomatic carriers, or be re-infected themselves. In an attempt to better understand these concerns, varying quarantine strategies have been implemented during the transition of COVID-19 recovering patients from healthcare to non-healthcare settings in this current pandemic.

Recently, the early experiences of 116 cases confirmed by nasopharyngeal swab testing, potentially resulting from either "reactivated" or "re-infected" SARS-CoV-2, was reported in South Korea 3, 4 . In response, the World Health Organization (WHO) commented that there is currently "no evidence" demonstrating that people who have recovered from the coronavirus are not at risk of re-infection 5 .

However, limited information is available regarding viral shedding kinetics and live virus isolation. Variability in PCR methodology will result in different thresholds . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. . https://doi.org/10.1101/2020.05.06.20089573 doi: medRxiv preprint of the assay for RNA detection, but in one study the SARS-CoV-2 RNA threshold upon PCR testing needs to be greater than 10 6 copies per sample 6 In order to assist with pandemic management, a better understanding of the recurrence of SARS-CoV-2 and associated potential infectivity in the setting of strict quarantine is critical. Similarly, to assist in managing individuals, setting quarantine strategies and adjudicating limited healthcare resources, prediction models are needed to better define the risk, timing, and relevance of viral PCR retest positivity.

Unanswered questions include: time between nasopharyngeal swab test negative and length of effective quarantine, and how infectious is an infected person who recurred with PCR positivity after testing negative. Pragmatic models should seek to define when recovered patients can be infectious, including in the cohort of individuals who recur with PCR positivity relative to testing interval. Thus, limited resources can be concentrated on the isolation of these potential SARS-CoV-2 carriers, with immediate benefits for the patient, the population and the healthcare system.

This study characterizes a single center cohort of consecutive patients with COVID-19 who were followed after recovery and PCR negativity and shown to have . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 10, 2020. . https://doi.org/10.1101/2020.05.06.20089573 doi: medRxiv preprint one or more recurrent positive PCR result despite continued quarantine. The primary objective was to describe the kinetics of SARS-CoV-2 PCR in a large cohort of infected individuals and better understand the relevance of recurrent positive results. The secondary objective was to develop a prediction algorithm to identify patients at high risk of the recurrent PCR positivity and provide practical data that may impact medical operation, health care policy, and case management.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 10, 2020. 

The study cohort included consecutive COVID-19 patients admitted to The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China since January 11, 2020. The last follow up date was April 23, 2020.

All discharged COVID-19 patients were subjected to strict quarantine at a designated center for 14 days. SARS-CoV-2 quantitative reverse transcription polymerase chain reaction (qRT-PCR) RNA testing was performed every 3 to 5 days during both hospitalization and quarantine. Follow-up at home quarantine was mandated for an additional 14 days with weekly SARS-CoV-2 qRT-PCR testing. Upon positive nasopharyngeal swab testing, according to the local health policy, these patients were immediately readmitted back to the hospital (Supplementary Figure 1) . This study was approved by the Ethics Committee of the Second Affiliated Hospital of Southern University of Science and Technology. Written informed consent was obtained from all patients.

Demographic features, comorbidities, clinical symptoms, vital signs, laboratory findings and treatments during the first hospitalization were collected. Sequentially from admission, nasopharyngeal swab testing was performed every 3 days during hospitalization. Reported treatment information includes medicines, intensive care unit (ICU) admissions, and respiratory support and ventilation usage.

Diagnosis, disease severity, treatment and follow-up criteria for COVID-19

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 10, 2020. The discharge criteria included: being afebrile for at least three days, resolved respiratory symptoms, improvement of radiological abnormities in CT or X-ray, and two consecutive negative SARS-Cov-2 qRT-PCR tests sampled >1 day apart. All patients were discharged under strict monitoring conditions: patients were kept for 14 days at a designated center followed by another 14 days at home, in quarantine, and all discharged patients were tested with repeated routine SARS-CoV-2 qRT-PCR detections in nasopharyngeal swab samples. According to the local quarantine policy, patients with a positive SARS-CoV-2 qRT-PCR nasopharyngeal test were immediately readmitted back to the hospital.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 10, 2020. . https://doi.org/10.1101/2020.05.06.20089573 doi: medRxiv preprint Early morning nasopharyngeal swabs (from January 12, 2020) and anal swabs (from February 2, 2020) were analyzed every 3 days during the hospitalization, every 3 to 5 days during mandated quarantine at a designated center, and weekly during quarantine at home. Bronchoalveolar lavage washing was sampled from patients with severe illness or undergoing mechanical ventilation. Total RNA was extracted from the clinical specimens using the QIAamp RNA Viral Kit (Qiagen, Heiden, Germany). A qRT-PCR Test Kit (product code. GZ-D2RM25, Shanghai GeneoDx Biotech Co., Ltd) targeting the ORF1ab and N genes of SARS-CoV-2 was used. A cycle threshold (Ct) value less than 37 was interpreted as positive for SARS-CoV-2 RNA 9 .

SARS-CoV-2 antibody Chemiluminescent microparticle immunoassay (CMIA) kit (Innodx, Xiamen, China; catalog no. Gxzz 20203400198) was used to detect SARS-CoV-2 IgM and IgG in plasma.

Patients who had a positive nasopharyngeal swab test during post-discharge follow-up and were readmitted to hospital were defined as 'case'. Patients who did not have positive results of nasopharyngeal swab test after discharge were analyzed as 'control' patients.

Features including demographics, comorbidities, symptoms, vital signs, laboratory findings, and treatments were assembled for modelling. Univariable analysis was performed on z-score-normalized features, and logistic regression was used to calculate the odds ratios and P values for feature filtering. For multivariate . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. . https://doi.org/10.1101/2020.05.06.20089573 doi: medRxiv preprint model building, a gradient boosting tree algorithm XGBoost was used for constructing a multivariable prediction model [10] [11] [12] [13] [14] [15] [16] . The baseline learner is the classification and regression tree and the number of trees is selected via cross-validation to avoid over-fitting. The derived model score ranged from 0 to 100 describing the probability of recurrence after discharge. The recurrence prediction model was evaluated using area under the receiver-operating-characteristic curve (ROC AUC), sensitivity, and specificity from the 10-fold cross-validations. Statistical analyses were performed using R software (version 3.5.1).

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. . https://doi.org/10.1101/2020.05.06.20089573 doi: medRxiv preprint

The study comprised a total of 417 consecutive patients admitted to the hospital with COVID-19 who were categorized to have mild (N=16), moderate (N=309), severe (N=73), or critical (N=19) conditions of pulmonary respiratory syndrome. Demographics, clinical data, PCR data, and outcomes from the first hospitalization are summarized (Table 1, Table 2 Within the case group, 70% retested positive within 5-25 days after the first negative test, with a peak occurring at 10-15 days (22%).

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. COVID-19 patients with multiple recurrence of PCR positivity have not been previously reported. Thirteen and three cases recurred two and three times with PCR positivity, respectively, making it likely that the re-emergence of PCR positivity is due . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. . https://doi.org/10.1101/2020.05.06.20089573 doi: medRxiv preprint to cycling between dormancy and reactivation of SARS-CoV-2, and/or the resurfacing of the virus from the lower tract to the upper tract of the respiratory system. However, it must be noted that the positive SARS-CoV-2 test does not equate with infectivity. Since the current standard for SARS-CoV-2 test positivity is predicated on viral load detection by PCR 6 , sample testing in the case cohort of <10 6 copies per sample may not represent a live virus isolate. Unless equipped with a live virus isolate, we cannot be certain whether these retest positive patients were capable of infecting others (contagious) given that they were quarantined at a designated center.

Ninety-three percent of the retest positive patients had mild or moderate severity disease during their first hospitalization. No obvious trending was found in this case series between the initial viral load and first admission symptoms, e.g. Figure 7) . This is in line with a previous report that The key rationale of the local health policy for implementing the described strict center-based quarantine is to prevent transmission. Our findings demonstrate that the effectiveness of this quarantine strategy in the management of the pandemic may be crucial in minimizing late transmission. They also provide . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. 

This case series demonstrates that recurrence of SARS-CoV-2 RNA positivity following hospital discharge is relatively common, with a 16.7% rate. Younger patients with less severe index illness were more likely to retest positive. More information will be required to understand the relevance of these findings, which will be critical for informing the management of the pandemic. Our prediction algorithm to identify patients at high risk of recurrence of PCR positivity may facilitate health policy.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. Patients are grouped by the number of (re)admissions. Clinical events include admission, nasopharyngeal swab tested negative, discharge, and quarantine ended due to either retest positive or release to home. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. . https://doi.org/10.1101/2020.05.06.20089573 doi: medRxiv preprint Figure 1 . This timeline summarizes the median duration (days) from the onset of symptoms to clinical events and recurrence of nasopharyngeal swab PCR positivity. Patients are grouped by the number of (re)admissions. Clinical events include admission, nasopharyngeal swab tested negative, discharge, and quarantine ended due to either retest positive or release to home.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. high-risk patients were applied, giving an overall sensitivity of 93%, 81%, and 68%, respectively.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 10, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 10, 2020. Table 2 continues in next column . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 10, 2020. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 10, 2020. . https://doi.org/10.1101/2020.05.06.20089573 doi: medRxiv preprint

Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy

Covid-19 -The Law and Limits of Quarantine

Risk of reactivation or reinfection of novel coronavirus (COVID-19)

South Korea reports more recovered coronavirus patients testing positive again

WHO says there's 'no evidence' recovered coronavirus patients won't get reinfected

Virological assessment of hospitalized patients with COVID-2019

Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient

National Health Commission of the People's Republic of China and National Administration of Traditional Chinese Medicine. Diagnosis and Treatment Scheme for Novel Coronavirus Pneumonia (Trial)

Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections

Assessing Statewide All-Cause Future One-Year Mortality: Prospective Study With Implications for Quality of Life, Resource Utilization, and Medical Futility

Prediction of Incident Hypertension Within the Next Year: Prospective Study Using Statewide Electronic Health Records and Machine Learning

Prediction of the 1-Year Risk of Incident Lung Cancer: Prospective Study Using Electronic Health Records from the State of Maine

A Real-Time Early Warning System for Monitoring Inpatient Mortality Risk: Prospective Study Using Electronic Medical Record Data

Identification of elders at higher risk for fall with statewide electronic health records and a machine learning algorithm

Development of an early-warning system for high-risk patients for suicide attempt using deep learning and electronic health records

Estimating One-Year Risk of Incident Chronic Kidney Disease: Retrospective Development and Validation Study Using Electronic Medical Record Data From the State of Maine

Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19

Asymptomatic Patients with Novel Coronavirus Disease (COVID-19)

Otolaryngology Providers Must Be Alert for Patients with Mild and Asymptomatic COVID-19

The relative transmissibility of asymptomatic COVID-19 infections among close contacts

Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing study

Asymptomatic and Presymptomatic Infectors: Hidden Sources of COVID-19 Disease

Rapid Detection of Asymptomatic COVID-19 by CT Image-Guidance for Stereotactic Ablative Radiotherapy

CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan

Asymptomatic COVID-19 infection in a patient evaluated for ureteric colic: Radiological findings and impact on management

COVID-19 Pneumonia in Asymptomatic Trauma Patients

Presumptive asymptomatic COVID-19 carriers' estimation and expected person-to-person spreading among repatriated passengers returning from China

Asymptomatic and pre-symptomatic cases of COVID-19 contribution to spreading the epidemic and need for targeted control strategies

Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster

COVID-19 transmission through asymptomatic carriers is a challenge to containment. Influenza Other Respir Viruses

Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up

Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19

Potential biochemical markers to identify severe cases among COVID-19 patients

Kidney disease is associated with in-hospital death of patients with COVID-19

Validation and Deployment of a Real Time 30 Day